Analytical Testing for Biopharma | UK-Based Lab Services

Our UK Characterization Facility

High-performance structural and physicochemical analysis for biologics, biosimilars and complex molecules in the United Kingdom.

BioPharmaSpec’s UK laboratory provides advanced analytical testing and delivers services to the highest level of scientific and regulatory standards, playing a central role in the development and approval of complex biopharmaceuticals across the world.

Our UK scientists support every stage of the drug development cycle, delivering a diverse range of analytical services, regulatory-aligned workflows, and in-depth scientific expertise to help you move faster and smarter from research through approval.

BioPharmaSpec UK

BioPharmaSpec Ltd
Suite 3.1 Lido Medical Centre
St. Saviour’s Road, St. Saviour
Jersey, JE2 7LA
United Kingdom

Tel: +44 (0)1534 483493

Email: [email protected]

Facility Features:

• Serving UK, European and international biopharma clients
• Seamless collaboration through on-site and remote consultations
• Multiple MS platforms and instruments leveraging the latest technology (e.g. IMS, ECD, TQA, Q-TOF, MALDI-TOF)
• Comprehensive range of structural, physicochemical, and biophysical characterisation and testing
• Proven support for method development, global regulatory filings, and analytical consultancy

Our Expertise:

• State-of-the-art analytical instrumentation: Waters Cyclic, Xevo MRT, Q-TOF, Triple Quad, MALDI-TOF, SEC-MALS, UPLC, FT-IR, CD, SV-AUC
• Support from discovery through late-phase development and beyond
• Direct scientist-to-scientist communication for faster project progression
• Full compliance with ICH Q6B, EMA, MHRA, and FDA requirements
• Experience supporting IND, IMPD, BLA and MAA submissions
• Trusted and widely recognised for generating high quality, reliable, data across all study types

Core Analytical Services Available in the UK

Support for Your Biopharmaceutical

Trusted by Industry Leaders Across the Globe

Our UK laboratory is a hub of scientific innovation and regulatory insight. We support biopharmaceutical organisations across the UK, EU, US and Asia with science-first analytical capabilities tailored to reduce risk and accelerate drug development.

• Multidisciplinary team with deep scientific and regulatory knowledge
• Proven track record in supporting global drug submissions
• Rapid client onboarding, transparent communication, and strategic collaboration

Ready to Advance Your Biologic?

Speak to a BioPharmaSpec scientist today to scope your project, receive a tailored proposal, and discover how our UK team can help bring your pharmaceutical or biologic product to market.

Our Expert

Michael-John O’Connor

Michael-John (MJ) is Director of Biochemical Services at BioPharmaSpec and has extensive experience applying mass spectrometry to biosimilar comparability studies.